Cost of treating inpatient falciparum malaria on the Thai-Myanmar border

BACKGROUND: Despite demonstrated benefits and World Health Organization (WHO) endorsement, parenteral artesunate is the recommended treatment for patients with severe Plasmodium falciparum malaria in only one fifth of endemic countries. One possible reason for this slow uptake is that a treatment co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyaw, Shwe Sin, Drake, Tom, Ruangveerayuth, Ronatrai, Chierakul, Wirongrong, White, Nicholas J, Newton, Paul N, Lubell, Yoel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218997/
https://www.ncbi.nlm.nih.gov/pubmed/25351915
http://dx.doi.org/10.1186/1475-2875-13-416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218997/
https://www.ncbi.nlm.nih.gov/pubmed/25351915
http://dx.doi.org/10.1186/1475-2875-13-416

Ejemplares similares